Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Clinical Science (London, England : 1979)|June 1, 1986
Cation transport abnormalities in vivo in untreated essential hypertensionN A Boon, J K Aronson, K F Hallis, et al.
British Journal of Pharmacology|January 1, 1975
Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolitesD J Boullin, D G Grahame-Smith, R P Grimes, et al.
British Journal of Clinical Pharmacology|February 1, 1975
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazineD J Boullin, H F Woods, R P Grimes, et al.
British Journal of Clinical Pharmacology|September 1, 1990
The effect of oral salbutamol on cation transport measured in vivo in healthy volunteersA J Wood, C J Brearley, J K Aronson, et al.
Neuropharmacology|May 1, 1983
Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperoneA R Green, K O'Shaughnessy, M Hammond, et al.
The Journal of Trauma|February 1, 1984
The relationship between plasma catecholamines and severity of injury in manC L Davies, R J Newman, S G Molyneux, et al.
Pageof 17